New research reveals ketamine's safe use for treating eating disorders, offering hope for patients with comorbid treatment-resistant depression.
Elizabeth Wassenaar, MD, MS, CEDS-S, DFAPA
Advertisement
Articles by Elizabeth Wassenaar, MD, MS, CEDS-S, DFAPA
An expert discusses this comorbidity, plus the effects of semaglutide and other GLP-1 agonists on this patient population.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Whatever Happened to Psychopathology?
2
Positive Phase 3 Results: CTx-1301 for the Treatment of Pediatric ADHD
3
How Can Chatbots Be Made Safe for Psychiatric Patients
4
Who Should Avoid Halloween Tricks and Treats?
5
